ADAR1 Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Sell |
10,000
-25,743
| -72% | -$291K | 0.02% | 162 |
|
|
2025
Q1 | $412K | Sell |
35,743
-100
| -0.3% | -$1.15K | 0.08% | 112 |
|
|
2024
Q4 | $304K | Buy |
35,843
+21,700
| +153% | +$184K | 0.06% | 128 |
|
|
2024
Q3 | $164K | Buy |
14,143
+2,123
| +18% | +$24.6K | 0.03% | 159 |
|
|
2024
Q2 | $142K | Buy |
12,020
+2,020
| +20% | +$23.8K | 0.03% | 149 |
|
|
2024
Q1 | $119K | Buy |
+10,000
| New | +$119K | 0.03% | 129 |
|